SYDNEY TMS FOR DEPRESSION, ANXIETY AND OCD
A dedicated and holistic mental health practice and a space for you to slow down, be mindful and enhance your mental wellbeing.
- Non-invasive brain stimulation delivered by trained clinicians
- Medicare rebates available for eligible clients
- Generally well tolerated, low side-effect profile
- A non-medication alternative depression treatment
AwareHub SYDNEY TMS
and BUNDABERG TMS
AwareHub has been successfully treating the TMS Sydney community from its bespoke premises in the heart of Bondi Junction since 2022. We are excited to announce that our TMS Sydney treatment program has now expanded to Bundaberg at The Friendlies Medical Suites. Please send TMS enquiries to BundabergTMS@awarehub.com.aus
What is TMS?
TMS is a simple, non-invasive procedure that uses a magnetic field to either stimulate or inhibit neurons in particular areas of the brain to improve symptoms of depression. The precise mechanism of TMS is not entirely understood, but studies suggest that it involves modulating brain activity and connection of relevant brain networks to ultimately effect symptom change.
The majority evidence supports the use of TMS in depression, and therefore TMS is approved to treat depression (where medications have failed or are not tolerable). TMS may be a treatment option for other mental health and neurological conditions.
TMS is typically used when other treatments haven’t been effective or if medications are not tolerated due to unwanted side effects. Some clients also prefer a non-medication approach to manage their mental health.
Data on real-world effectiveness in the United States reported response rates of 58–83% for TMS treatment of depression.
TMS has a low side effect profile and is typically well tolerated. TMS does not cause ‘personality changes’ or cognitive side effects. Clients remain alert throughout the duration of the treatment and following the treatment, are able to return to their daily tasks.
It is important to discuss the option of TMS with an appropriate health professional.
WHAT OUR CLIENTS SAY ABOUT TMS
Our TreatING TeaM
Our team of experienced healthcare professionals servicing the TMS Sydney and Bundaberg communities are dedicated to providing the highest quality care. The safety and efficacy of TMS for treating depression has been established in several well-controlled research studies, including a study sponsored by the National Institute of Mental Health. Since 2008 over 20,000 patients have undergone TMS treatment. There are over 30 studies demonstrating the efficacy of TMS as treatment for depression in adults.
Fees
Please contact tms@awarehub.com.au to enquire about TMS Sydney fees and rebates. In Bundaberg, please email bundabergTMS@awarehub.com.au. Medicare subsidy applies under certain conditions.
SUPPORT SERVICES
Supporting eligible WorkCover (Workers Compensation) and Department of Veterans’ Affairs Australia (DVA) patients.
ADVANCES IN TMS TREATMENT RESEARCH
- Depression: TMS has been extensively studied and proven effective for treating depression and major depressive disorder (MDD), especially when traditional treatments have failed to provide optimal outcomes.
- Obsessive-Compulsive Disorder (OCD): TMS offers promising results for reducing OCD symptoms, particularly when the stimulation is targeted at specific brain regions involved in compulsive behaviours. OCD affects 2-3% of the Australian population. Many sufferers of OCD will not respond sufficiently to psychological therapy and medication and for these individuals, deep TMS is a reasonable option. Deep TMS is delivered with specific devices and approved coils, such as the double-cone coil used at AwareHub.
- Anxiety Disorders: Studies suggest TMS can be beneficial in managing anxiety disorders such as Generalised Anxiety Disorder. TMS used to treat depression, may also reduce any co-occurring anxiety.
- PTSD, Chronic Pain, Tinnitus, ASD, Eating Disorder, Addictions: Research is ongoing to explore the potential benefits of TMS for treating other mental health conditions.
FAQ
Transcranial Magnetic Stimulation (TMS) is a non‑invasive brain stimulation treatment that may be used for certain mental health conditions, most commonly depression. Magnetic pulses are delivered to targeted brain regions involved in mood regulation. TMS does not require anaesthesia and is performed while you are awake and seated comfortably. Treatment is typically delivered across multiple sessions over several weeks as part of a structured clinical program.
TMS may be considered for people experiencing depression or other conditions where symptoms have not adequately improved with standard treatments such as medication or psychological therapy. Suitability is determined following assessment with a psychiatrist to ensure the treatment is safe and appropriate for the individual.
During a TMS session, a magnetic coil is placed against the scalp and delivers targeted magnetic pulses to specific areas of the brain. Sessions typically last between 3 and 20 minutes, depending on the treatment protocol. Most people are able to return to normal daily activities afterwards. Driving is permitted following treatment.
TMS has been studied in clinical settings and is generally considered safe when delivered by trained clinicians following appropriate screening. As with any medical treatment, suitability and potential risks are assessed before treatment begins. Your clinician will discuss whether TMS may be appropriate for your individual situation.
In many cases, TMS may be provided alongside existing medication treatment. Decisions about medication use during TMS are made by the treating psychiatrist based on clinical history, safety considerations and individual treatment goals.
TMS may be eligible for Medicare funding when specific clinical criteria are met, particularly for treatment‑resistant depression. Eligibility is determined through assessment with a psychiatrist. Our team can discuss whether Medicare funding may apply in your situation.
Treatment‑resistant depression generally refers to depression that has not adequately improved after at least two adequate trials of antidepressant medication. In these situations, clinicians may consider additional treatment options following further clinical assessment.
